Nextkidney B.V.

About Nextkidney B.V.

Nextkidney is focused on improving the quality of life for dialysis patients by developing portable hemodialysis solutions. Their mission is to restore freedom and control to patients through innovative, user-friendly, and sustainable medical devices that fit into patients' lifestyles.

Products & Services

Neokidney:A portable hemodialysis device that is compact (close to 10kg), lightweight, and designed to fit into cabin-size luggage. It offers flexibility for home dialysis, freedom of movement, and a user-friendly interface for ease of use by patients and caregivers.

Specialties

Portable Hemodialysis Devices Home Dialysis Solutions Patient-Centered Medical Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 12709200 MR: - FA: 11.9 million EUR FAN: 12709200	D: 2023-02-16 FD: 2023-02-16	2 investors

Series B Latest

2023-02-16

$12.7M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jérôme Augustin

Chief Executive Officer

J

John Stooker

Chief Operating Officer & Chief Financial Officer

C

Christian Bluechel

Chief Technological Officer

C

Christophe Conan

R&D Director

J

Jasmin Wong

Chief Executive Officer Nextkidney Singapore

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

Nextkidney B.V. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised